Albany Molecular
Article Abstract:
The price appreciation potential of the shares of Albany Molecular Research Inc. for the years 2010-2012 is discussed. The Albany, New York-based company is a contract research organization that focuses on applications for the pharmaceuticals, biotechnology, and life sciences industries.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Albany Molecular Research Inc., AMRI, Analyst report
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Illumina, Inc
Article Abstract:
The stock of Illumina Inc. offers worthwhile capital appreciation over the next three to five years. The San Diego, California-based company manufactures tools for analysis of genetic variation and biological function.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Illumina Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Evaluation, Biotechnology industry, Biotechnology industries, Stocks, Securities, Stock prices, Company securities
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.